Rat Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Protein

Este producto es parte de KDR - kinase insert domain receptor
Product Graph
1118€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Rat Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx691493
tested applications
SDS-PAGE

Description

Rat Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Protein is a recombinant protein from Rat produced in HEK293 Cells. A DNA sequence encoding the rat KDR (AAH87029.1) extracellular domain (Met 1-Glu 760) was expressed with a polyhistidine tag at the C-terminus.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR)
Host
HEK293 cells
Assay Type
Activity: Not tested
Sequence Fragment: Met1-Glu760
Tag: C-terminal His tag
Origin
Rat
Observed MW
84.3 kDa
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
50 µg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Lyophilized from sterile PBS, pH 7.4.
Availability
Shipped within 5-15 working days.
Storage
Storage: Store lyophilized between -20 °C and -80°C.
Stability: Stable when stored reconstituted at 2-8°C for up to 1 week. Reconstituted aliquots are stable at -20°C for up to 3 months.
Shelf Life: 12 months.
Dry Ice
No
NCBI Accession
EDM04022.1
Alias
FLK1,CD309,VEGFR,VEGFR2,VEGFR-2,Protein-tyrosine kinase receptor flk-1,Fetal liver kinase 1,Vascular endothelial growth factor receptor 2
Background
Protein KDR
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

KDR, also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a critical protein in the regulation of angiogenesis and vascular development. This receptor tyrosine kinase (RTK) is encoded by the KDR gene located on chromosome 4q12 in humans. KDR is a member of the VEGF receptor family, which plays an essential role in the processes of vasculogenesis and angiogenesis by mediating the cellular responses to the vascular endothelial growth factor (VEGF). The VEGF family consists of several ligands, with VEGF-A being the primary ligand for KDR. KDR is predominantly expressed in endothelial cells, where it regulates vascular permeability, endothelial cell proliferation, migration, and survival. Due to its pivotal role in vascular biology, KDR has been extensively studied in the context of cancer, where angiogenesis is a crucial process for tumor growth and metastasis. KDR's involvement in pathological angiogenesis makes it a significant target for anti-angiogenic therapies in cancer treatment. Moreover, it has implications in other diseases characterized by abnormal vascular growth, such as age-related macular degeneration and rheumatoid arthritis.

Related Products

EH0329

Human VEGFR2/KDR (Vascular endothelial growth factor receptor 2) ELISA Kit

Ver Producto
EM1445

Mouse VEGFR-2/KDR (Vascuoar Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto
ER20009

Rat VEGFR2/KDR (Vascular Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto